Musk's Neuralink to start human trials on paralysis patients

FREMONT, California: This week, brain-chip startup Neuralink, owned by billionaire Tesla CEO Elon Musk, said an independent review board granted it approval to begin recruiting volunteers for the first human trial of its brain implant for paralysis patients.

The company added that people with paralysis due to cervical spinal cord injury or amyotrophic lateral sclerosis could qualify for the six-year trial.